High Pressure versus High Flow: What Should We Target in Acute Respiratory Failure?
High Pressure versus High Flow: What Should We Target in Acute Respiratory Failure?
复制标题
高压与高流量:急性呼吸衰竭时我们应该瞄准什么?
DOI:
10.1164/rccm.201911-2196ed
复制
发表时间:
2020
影响因子:
24.7
通讯作者:
Yoshida Takeshi
中科院分区:
文献类型:
--
作者:
Thille Arnaud W.;Yoshida Takeshi
In this issue of the Journal, Grieco and colleagues (pp. 303–312) compare high-flow nasal cannula (HFNC) oxygenation versus noninvasive ventilation (NIV) delivering high levels of pressure using a helmet (1). In this physiological study, 15 patients with acute respiratory failure (PaO2/FIO2, 200 mm Hg) were treated in a randomized crossover fashion by HFNC with a flow of 50 L/min or by NIV using a helmet with a high pressure-support level (10–15 cm H2O) and a positive end-expiratory pressure (PEEP) of at least 10 cm H2O, with each phase lasting 60 minutes. Compared with HFNC, NIV with a helmet markedly improved oxygenation and significantly reduced dyspnea, respiratory rate, and patient effort, whereas comfort and PCO2 did not differ between the two techniques.The management of acute hypoxemic respiratory failure in the ICU is challenging. In the most recent clinical practice guidelines, the use of NIV with a face mask was discussed, but the experts were unable to offer a recommendation (2). Patients with acute respiratory failure who have failed NIV are now known to have a vigorous respiratory drive, and such patients have a particularly poor prognosis (3, 4). Therefore, management to protect the already injured lung from the patient’s vigorous spontaneous efforts (ie, self-inflicted lung injury) is needed in this particular setting (5). Furthermore, synchronization between the patient’s intense respiratory drive to breath and the pressure support delivered by NIV may result in high VTs that may worsen lung
登录
查看更多内容
DOI:
10.1164/rccm.201605-1081cp
发表时间:
2017-02-15
影响因子:
24.7
作者:
Brochard, Laurent;Slutsky, Arthur;Pesenti, Antonio
通讯作者:
Pesenti, Antonio
DOI:
10.1001/jama.2016.6338
发表时间:
2016-06-14
期刊:
JAMA
影响因子:
--
作者:
Patel BK;Wolfe KS;Pohlman AS;Hall JB;Kress JP
通讯作者:
Kress JP
影响因子:
2.2
作者:
Regan EA;Hokanson JE;Murphy JR;Make B;Lynch DA;Beaty TH;Curran-Everett D;Silverman EK;Crapo JD
通讯作者:
Crapo JD
影响因子:
8.8
作者:
Antonelli, M;Conti, G;Proietti, R
通讯作者:
Proietti, R
影响因子:
168.9
作者:
B. Burrows;C. Fletcher;B. Heard;N. Jones;J. S. Wootliff
通讯作者:
J. S. Wootliff